Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2011
01/13/2011US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists
01/13/2011US20110009413 Cyclic triazo and diazo sodium channel blockers
01/13/2011US20110009407 Pyridinone antagonists of alpha-4 integrins
01/13/2011US20110009398 p27 Protein Inducer
01/13/2011US20110009396 Tricyclic compounds for the treatment of inflammatory disorders
01/13/2011US20110009379 Indolinone compound
01/13/2011US20110005947 Inhibitors of jak
01/13/2011CA2775312A1 Substituted phenyl(oxy/thio)alkanol derivatives
01/13/2011CA2767489A1 A crystalline form of posaconazole
01/13/2011CA2766643A1 Tofa analogs useful in treating dermatological disorders or conditions
01/13/2011CA2766343A1 Platelet-activating factor receptor antagonists
01/12/2011EP2272843A1 Quinoline compound
01/12/2011EP2272842A1 Process for the manufacture of the calcium salt of rosuvastatin and crystalline intermediates thereof
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/12/2011EP2271641A1 Fungicide hydroximoyl-heterocycles derivatives
01/12/2011EP2271629A1 Substituted pyrimidin-5-carboxamides 281
01/12/2011EP2271621A1 Pyridyl derivatives as cftr modulators
01/12/2011EP2035415B1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
01/12/2011EP1797062B1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
01/12/2011EP1670784B1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
01/12/2011EP1490357B1 Toluene solvate of darifenacin
01/12/2011CN101945879A Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
01/12/2011CN101945856A Herbicidal pyridazinone derivatives
01/12/2011CN101941917A Amide compounds and use thereof
01/12/2011CN101414662B Organic electronic transmission and/or positive hole countercheck material, and synthesizing method and purpose thereof
01/12/2011CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives
01/11/2011US7868225 Artichoke hybrid named ‘PS-H2015’
01/11/2011US7868178 4-Phenoxy-, 4-phenylthio-, 4-phenylsulfonyl- or 5-phenylsulfinyl-1-(2-pyridinyl)pyrrolidene derivatives; e.g. 3-[4-(trifluoromethyl)phenoxy]-1-[5-(trifluoromethyl)-2-pyridyl]pyrrolidine insecticides, miticides and nematocides
01/11/2011US7868047 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
01/11/2011US7868034 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
01/11/2011US7868028 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants
01/11/2011US7868013 Cycloalkyl substituted pyrimidinediamine compounds and their uses
01/11/2011US7867994 reacting 3-[2-(1,3-dioxolan-2-yl)ethyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, with 7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N-methylmethanamine hydrochloride, in the presence of hydrogen and palladium supported on carbon, to give ivabradine hydrochloride; bradycardial agents
01/11/2011CA2536384C Cyclic derivatives as modulators of chemokine receptor activity
01/11/2011CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative
01/11/2011CA2460696C Use of substituted aminomethyl chromans for the treatment of extrapyramidal movement disorders
01/11/2011CA2449555C Hydroxylation of beta-dicarbonyls with zirconium catalysts
01/11/2011CA2407593C Fused heteroaryl derivatives
01/11/2011CA2385592C Benzamides and related inhibitors of factor xa
01/11/2011CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors
01/06/2011WO2011002910A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
01/06/2011WO2011002871A2 Isomannide derivatives and their use as tastants
01/06/2011WO2011002405A1 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
01/06/2011WO2011002067A1 Heterocyclic compound and use thereof
01/06/2011WO2011001419A1 Covalent inhibition of bacterial quorum sensing
01/06/2011WO2010099206A3 Alkene aziridination
01/06/2011US20110003991 Piperazine derivatives and their use in controlling pests
01/06/2011US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
01/06/2011US20110003877 SMAC Mimetic
01/06/2011US20110003861 2-aryl and 2-heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain
01/06/2011US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses
01/06/2011US20110003859 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
01/06/2011US20110003853 Metalloproteinase Inhibitors
01/06/2011US20110003830 Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and solvates thereof
01/06/2011US20110003825 Substituted amide beta secretase inhibitors
01/06/2011US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels
01/06/2011US20110003808 Octahydroquinolizines for antidiabetic treatment
01/06/2011US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
01/06/2011US20110002995 Pharmaceutical composition for the treatment and prevention of cardiac disease
01/06/2011CA2767183A1 Covalent inhibition of bacterial quorum sensing
01/06/2011CA2766882A1 Therapeutic compounds and compositions
01/06/2011CA2765475A1 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
01/05/2011EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands
01/05/2011EP2270005A1 Prodrug of an ice inhibitor
01/05/2011EP2270004A1 Caspase inhibitors and uses thereof
01/05/2011EP2270003A1 Novel processes for the preparation of a 2H-chromene
01/05/2011EP2270002A1 Quinazoline derivatives as histamine H4-receptor inhibitors for use in the treatment of inflammatory disorders
01/05/2011EP2269993A1 2-aminoquinazoline derivative
01/05/2011EP2269985A2 Substituted tetracycline compounds
01/05/2011EP2268631A1 Aminopiperidinyl derivatives and uses thereof
01/05/2011EP2268630A2 Hexahydrocyclopentylýf¨indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
01/05/2011EP2268628A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
01/05/2011EP2268624A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
01/05/2011EP1881977B1 Histone deacetylase inhibitors
01/05/2011EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
01/05/2011EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
01/05/2011CN101939297A Benzylpiperizine compound
01/05/2011CN101939055A 2-aminoquinolines
01/05/2011CN101939053A Soluble guanylate cyclase activators
01/05/2011CN101935303A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
01/05/2011CN101935301A Modulators of ATP-binding cassette transporters
01/05/2011CN101935299A Organic electron transport and/or cavitation block material and synthesis method and application thereof
01/04/2011US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
01/04/2011US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
01/04/2011US7863314 Pyrazole and/or imidazole based compounds; inflammatory diseases and disorders; synthesis
01/04/2011US7863313 Methods for the treatment of inflammatory diseases
01/04/2011US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders
01/04/2011US7863281 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct
01/04/2011US7863220 Herbicidal pyrimidines
01/04/2011US7863048 Coumarin-based cyanine dyes for non-specific protein binding
01/04/2011CA2577667C 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie
01/04/2011CA2555331C Therapeutic agents
01/04/2011CA2521271C Quinoline-2-one-derivatives for the treatment of airways diseases
01/04/2011CA2465207C Pyrazole-amides and -sulfonamides
01/04/2011CA2458533C Imidazole derivates as anti-inflammatory agents
01/04/2011CA2451393C 2 pyrrolidone derivatives as prostanoid agonists
01/04/2011CA2413426C Methods and compositions utilizing quinazolinones
01/04/2011CA2412941C Piperidine compounds for use as ccr-3 inhibitors
01/04/2011CA2375008C Phenoxypropylamine compounds
01/04/2011CA2362132C Novel intermediate for the synthesis of prostaglandins